Ons 1 dec / År 39 / Nr 4 2021

Life Science 2021

The task of developing the healthcare systems, technology and treatments of the future requires a much sharper focus on facilitating collaboration across borders. Not only geographical – but across disciplines as well. Gothenburg has a strong and growing Life Science cluster which deserves to be highlighted from a national point of view.

Mölnlycke bolsters digitisation and new technologies to keep the lead in next generation wound care

Mölnlycke revolutionised wound care worldwide by introducing Safetac over 20 years ago. Safetac enables painless changes of dressings on difficult-to-heal wounds, and manifests Mölnlycke’s vision of giving patients better experiences in wound care.

Malin Andersson, Vice President Wound Care R&D, Annika Samuelsson, Director of People Experience and Daniel Frick Vice President IT / CIO.

The strong spirit of innovation is something that still characterises Mölnlycke and is noticeable through all new launches and innovations. Being innovative and pioneering in new areas seems to be embedded deeply within Mölnlycke’s DNA. A significant part of Mölnlycke’s R&D work is conducted out of Mölnlycke’s headquarters in Gothenburg.

The Swedish company, with 8,000 employees globally, focuses mainly on advanced wound care and to provide healthcare with surgical solutions, such as customised procedure trays, gloves, drapes and staff clothing. During the pandemic, providing healthcare professionals with personal protective equipment has also been a top priority.

Within wound care, a large part of Mölnlycke’s portfolio is built around Safetac. Modern wound care has also been developed thanks to Safetac. There is therefore a great legacy to manage for everyone who works at Mölnlycke today.

“We will continue to put patients first. Initially, we want to help patients avoid having these difficult-to-heal wounds. Once wounds have developed, we want to use our innovative products to ensure that wound healing is accelerated. We have a solid pipeline of new solutions and a strong focus on relieving disturbance in patients’ everyday lives”, states Malin Andersson, Vice President Wound Care R&D at Mölnlycke.

Expanded offer and the digital journey

No doubt, Mölnlycke has a heritage and a strong brand that is well known worldwide. Mölnlycke has a strong commitment to remaining a market leader in development of tomorrow’s smart and effective wound care. Digitisation and bringing more technology into the products will play increasingly a more important part in this effort.

“We have always had a strong entrepreneurship culture within Mölnlycke which is a really differentiating and valuable asset. Our new CEO Zlatko Rihter is a strong advocate of entrepreneurship and innovation, and we are on a path to put an even higher emphasis on developing and acquiring new technologies and capabilities. Our will to make a difference for patients around the world is only getting stronger”, explains Annika Samuelsson, Director of People Experience at Mölnlycke.

An acquisition that has expanded Mölnlyckes’ portfolio in the past years is within Oxygen Therapy, where the healing process is accelerated with the help of haemoglobin. Under its own auspices, Mölnlycke has also developed its own offering in many other therapies. An example is wound healing with the help of negative pressure, where a pump attached to the dressing is generating a vacuum in the wound bed and thereby stimulates the wound to heal quicker.

Making the experience of thousands of wounds accessible

“We are moving towards more advanced products and this field is developing at an increasingly high pace. At the same time, we make an exciting digital journey, both in our products and in our offer”, says Daniel Frick, Mölnlycke Health Care Vice President IT / CIO.

Daniel Frick continues to explain how Mölnlycke supports competence development among customers and users, healthcare staff and patients.

“A recent example is the launch of an app for Wound Support that caregivers can use as decision support to assess and treat wounds. This is just the beginning of what you can do with the help of digital aids. There is an entire ecosystem of services that can be digitised and thus create better conditions for healthcare professionals to treat wounds”.

In many countries, including Sweden, there are only limited numbers of clinical specialists in wound care. Hence, the digital Mölnlycke Wound Support that is currently being developed based on the experience of thousands of wounds can make an even bigger difference.

“At Mölnlycke we always put the patient in the centre of everything we do. We also recognise that difficult-to-heal wounds is a significant economic burden to society. It is a silent epidemic and an increasing problem resulting from welfare diseases and life style changes. Clearly, there is a mounting need to develop solutions to make wound care more efficient both for health care as well as for all patients suffering around the world. Channelling our vast joint experience, our industry leading talent and our strong ambition in this field, we are committed to continue to make a true difference in wound care by bringing new, innovative solutions to health care and patients”, says Malin Andersson.